Olumi AF - Search Results

1

Hypoxia-inducible factor linked to differential kidney cancer risk seen with type 2A and type 2B VHL mutations.

Li L, Zhang L, Zhang X, Yan Q, Minamishima YA, Olumi AF, Mao M, Bartz S, Kaelin WG Jr. Li L, et al. Among authors: olumi af. Mol Cell Biol. 2007 Aug;27(15):5381-92. doi: 10.1128/MCB.00282-07. Epub 2007 May 25. Mol Cell Biol. 2007. PMID: 17526729 Free PMC article.

2

Correction: Sirt1 coordinates with ERα to regulate autophagy and adiposity.

Tao Z, Shi L, Parke J, Zheng L, Gu W, Dong XC, Liu D, Wang Z, Olumi AF, Cheng Z. Tao Z, et al. Among authors: olumi af. Cell Death Discov. 2023 Jun 23;9(1):190. doi: 10.1038/s41420-023-01471-5. Cell Death Discov. 2023. PMID: 37353481 Free PMC article. No abstract available.

3

Persistent c-FLIP(L) expression is necessary and sufficient to maintain resistance to tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in prostate cancer.

Zhang X, Jin TG, Yang H, DeWolf WC, Khosravi-Far R, Olumi AF. Zhang X, et al. Among authors: olumi af. Cancer Res. 2004 Oct 1;64(19):7086-91. doi: 10.1158/0008-5472.CAN-04-1498. Cancer Res. 2004. PMID: 15466204

4

Lexatumumab (TRAIL-receptor 2 mAb) induces expression of DR5 and promotes apoptosis in primary and metastatic renal cell carcinoma in a mouse orthotopic model.

Zhang L, Zhang X, Barrisford GW, Olumi AF. Zhang L, et al. Among authors: olumi af. Cancer Lett. 2007 Jun 18;251(1):146-57. doi: 10.1016/j.canlet.2006.11.013. Epub 2006 Dec 20. Cancer Lett. 2007. PMID: 17184908

5

MG-132 sensitizes TRAIL-resistant prostate cancer cells by activating c-Fos/c-Jun heterodimers and repressing c-FLIP(L).

Li W, Zhang X, Olumi AF. Li W, et al. Among authors: olumi af. Cancer Res. 2007 Mar 1;67(5):2247-55. doi: 10.1158/0008-5472.CAN-06-3793. Cancer Res. 2007. PMID: 17332355

6

Novel targeted pro-apoptotic agents for the treatment of prostate cancer.

Huang X, Zhang X, Farahvash B, Olumi AF. Huang X, et al. Among authors: olumi af. J Urol. 2007 Nov;178(5):1846-54. doi: 10.1016/j.juro.2007.06.039. Epub 2007 Sep 17. J Urol. 2007. PMID: 17868738 Review.

7

c-Fos as a proapoptotic agent in TRAIL-induced apoptosis in prostate cancer cells.

Zhang X, Zhang L, Yang H, Huang X, Otu H, Libermann TA, DeWolf WC, Khosravi-Far R, Olumi AF. Zhang X, et al. Among authors: olumi af. Cancer Res. 2007 Oct 1;67(19):9425-34. doi: 10.1158/0008-5472.CAN-07-1310. Cancer Res. 2007. PMID: 17909052 Free PMC article.

8

pVHL acts as an adaptor to promote the inhibitory phosphorylation of the NF-kappaB agonist Card9 by CK2.

Yang H, Minamishima YA, Yan Q, Schlisio S, Ebert BL, Zhang X, Zhang L, Kim WY, Olumi AF, Kaelin WG Jr. Yang H, et al. Among authors: olumi af. Mol Cell. 2007 Oct 12;28(1):15-27. doi: 10.1016/j.molcel.2007.09.010. Mol Cell. 2007. PMID: 17936701 Free PMC article.

9

Low-dose 12-O-tetradecanoylphorbol-13-acetate enhances tumor necrosis factor related apoptosis-inducing ligand induced apoptosis in prostate cancer cells.

Zhang X, Li W, Olumi AF. Zhang X, et al. Among authors: olumi af. Clin Cancer Res. 2007 Dec 1;13(23):7181-90. doi: 10.1158/1078-0432.CCR-07-1133. Clin Cancer Res. 2007. PMID: 18056199

10

Overcoming resistance to trail-induced apoptosis in prostate cancer by regulation of c-FLIP.

Zhang X, Li W, Olumi AF. Zhang X, et al. Among authors: olumi af. Methods Enzymol. 2008;446:333-49. doi: 10.1016/S0076-6879(08)01620-0. Methods Enzymol. 2008. PMID: 18603132

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

121 results

Search Page

Filters